Private Sector (including Foundations)

Catholic Relief Services

Protecting children through Crush Malaria


Current pledge (2020-2022)
US$3 million
Partner since
2009

Catholic Relief Services (CRS) has been a long-standing partner of the Global Fund since 2009, implementing programs supported by the Global Fund to tackle malaria, HIV and TB across Africa.

The partnership includes Crush Malaria, a joint initiative from CRS and the Global Fund to raise awareness and additional funds to help fight malaria, one of the deadliest diseases on the planet – especially for children under 5.

Through fundraising activities within the United States Catholic communities, including colleges, high school youth and family foundations, Crush Malaria leverages and complements the strengths of both organizations by mobilizing significant additional resources and scaling up malaria programs in Africa.

The initiative focuses on Niger, considered one of the least developed countries in the world and among the countries most hard hit by malaria. The initiative aims to treat 1 million children with preventative medication across the vast country and help reduce the number of cases among children by 60%.

Crush Malaria provides to children lifesaving prevention medication called seasonal malaria chemoprevention. Seasonal malaria chemoprevention is a cost-effective method that has led to a dramatic decline in malaria cases. The treatment, which costs just US$5 per child, is given to children before the peak malaria season, and can be easily administered by community health workers in remote communities, making it a sustainable approach in rural areas.

"It is not acceptable that a preventable disease continues to cause so much suffering in countries like Niger. Joining with the Global Fund greatly expands our capacity to fight malaria. It brings us one step closer to our shared goal of ending the malaria epidemic by 2030."
Sean Callahan, CEO and President, Catholic Relief Services

Pledge and contribution data updated on: 17 November 2021